sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.

sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.

Item
http://www.wikidata.org/entity/Q40150613
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapyThe role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaTargeting the Bcl-2 family for cancer therapyEmerging Bcl-2 inhibitors for the treatment of cancer.Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017): a novel scaffold that resensitizes multidrug resistant leukemia cells to chemotherapyNon-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.The Bcl-2 antagonist HA14-1 forms a fluorescent albumin complex that can be mistaken for several oxidized ROS probes.Chromenes: potential new chemotherapeutic agents for cancer.The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.FeCl3-catalyzed dimerization/elimination of 1,1-diarylalkenes: efficient synthesis of functionalized 4H-chromenes.Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells.Curcumin and quercetin trigger apoptosis during benzo(a)pyrene-induced lung carcinogenesis.Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells
P2860

sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.

Item
http://www.wikidata.org/entity/Q40150613
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
sHA 14-1, a stable and ROS-fre ...... rapies in human leukemia cell.
@en
type
label
sHA 14-1, a stable and ROS-fre ...... rapies in human leukemia cell.
@en
prefLabel
sHA 14-1, a stable and ROS-fre ...... rapies in human leukemia cell.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
sHA 14-1, a stable and ROS-fre ...... rapies in human leukemia cell.
@en
P2093
P2860
P304
P31
P356
10.1016/J.CANLET.2007.10.012
P407
P433
P478
P577
P5875
P698
P921
P932